XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (19,019,785) $ (18,725,716)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 1,441,152 2,354,357
Change in fair value of warrants (438,000) (2,898,892)
Non-cash other financing costs   1,820,129
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 1,471,155 2,728,598
Accounts payable (193,948) 2,806,577
Accrued expenses 46,758 (1,694,311)
Net cash used in operating activities (16,692,668) (13,609,258)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 21,427,151 12,466,165
Proceeds from exercise of warrants   8,025,003
Net cash provided by financing activities 21,427,151 20,491,168
Net increase in cash and cash equivalents 4,734,483 6,881,910
Cash and cash equivalents, beginning of period 10,551,916 5,754,720
Cash and cash equivalents, end of period $ 15,286,399 12,636,630
Supplemental disclosure of cash flow information:    
Other adjustments to value of warrants related to exercises   9,317,108
Cash paid for financing costs   $ 50,000